The “smart money” have been buying up shares in these 16 companies, and analysts say 2 of them could see MASSIVE upside ahead.
Read MoreWhy one JPMorgan analyst says this stock could see more than 25% upside on the horizon.
Read MoreMorgan Stanley isn’t the only firm upgrading this stock. Here’s why analysts say it “has room to run.”
Read MoreTrade Setup Buy Target – $5.75 or better Sell Target – TradersPro Sell Signal Avadel Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, France, and Ireland. The company primarily develops FT218, which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) […]
Read MorePlus, the market is digesting mixed signals on the trade front, Xerox sent an ultimatum to HP Inc, and Macy’s disappointed in its earnings report.
Read MoreIt’s no big surprise to say that trade tensions are continuing to play out at the forefront of investor’s famously short attention span. So far this week, rumors that the eagerly anticipated “Phase One” of a trade deal between the U.S. and China might not happen before the end of the year seem to have […]
Read More